New Jersey-Based Johnson & Johnson Begins Testing Ebola Vaccine
New Brunswick, New Jersey-based Johnson & Johnson has begun testing an Ebola vaccine in humans, intended to counter a strain of the virus similar to the one that has wreaked havoc in West Africa.
